51.365
USD
-0.33
(-0.64%)
Market Closed
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 0.23Revenue estimate 1.25B
Q4 FY2026 · Earnings report
EPS estimate 0.23Revenue estimate 1.25B
Genmab A market capWhat is market capitalization? Market cap is what the stock market values a whole company at: its share price times the number of its shares outstanding.
Genmab A/S ADS's market cap is 31.67B USD: 616,593,650 shares outstanding at today's price of 51.37.
- Today
- 31.67B
- Average, 5 years
- 20.14B
- Low, 5 years
- 11.67B
- High, 5 years
- 35.17B
Market cap = price × shares outstanding = 51.37 × 616.59M = 31.67B
Each day's closing price times the shares outstanding in the last 10-Q or 10-K filed by then (the quarter's basic share count, adjusted for splits); from the latest count on, the shares outstanding now.
Market cap by year and by quarter
| Fiscal year | Period ending | Market cap |
|---|---|---|
| Today | 31.67B | |
| FY2025 | 31 Dec 2025 | 19.14B |
| FY2024 | 31 Dec 2024 | 97.16B |
| FY2023 | 31 Dec 2023 | 141.71B |
| FY2022 | 31 Dec 2022 | 192.46B |
| FY2021 | 31 Dec 2021 | 169.12B |
| FY2020 | 31 Dec 2020 | 161.42B |
| FY2019 | 31 Dec 2019 | 93.69B |
| FY2018 | 31 Dec 2018 | 65.75B |
| FY2017 | 31 Dec 2017 | 62.57B |
| FY2016 | 31 Dec 2016 | 70.16B |
| FY2015 | 31 Dec 2015 | 53.84B |
| FY2014 | 31 Dec 2014 | 20.31B |
| FY2013 | 31 Dec 2013 | 10.78B |
| FY2012 | 31 Dec 2012 | 3.64B |
| FY2011 | 31 Dec 2011 | 1.68B |
| FY2010 | 31 Dec 2010 | 3.38B |
| FY2009 | 31 Dec 2009 | 3.52B |
| FY2008 | 31 Dec 2008 | 8.97B |
| FY2007 | 31 Dec 2007 | 8.46B |
| FY2006 | 31 Dec 2006 | 8.29B |
| FY2005 | 31 Dec 2005 | 7.42B |
| FY2004 | 31 Dec 2004 | 5.47B |
| FY2003 | 31 Dec 2003 | 5.09B |
| FY2002 | 31 Dec 2002 | 5.24B |
| Quarter | Period ending | Market cap |
|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 21.86B |
| Q2 FY2026 | 30 Jun 2026 | 16.85B |
| Q1 FY2026 | 31 Mar 2026 | 16.47B |
| Q4 FY2025 | 31 Dec 2025 | 18.98B |
| Q3 FY2025 | 30 Sept 2025 | 18.89B |
| Q2 FY2025 | 30 Jun 2025 | 12.76B |
| Q1 FY2025 | 31 Mar 2025 | 12.48B |
| Q4 FY2024 | 31 Dec 2024 | 96.44B |
| Q3 FY2024 | 30 Sept 2024 | 105.90B |
| Q2 FY2024 | 30 Jun 2024 | 111.84B |
| Q1 FY2024 | 31 Mar 2024 | 137.24B |
| Q4 FY2023 | 31 Dec 2023 | 140.40B |
| Q3 FY2023 | 30 Sept 2023 | 162.43B |
| Q2 FY2023 | 30 Jun 2023 | 169.22B |
| Q1 FY2023 | 31 Mar 2023 | 169.73B |
| Q4 FY2022 | 31 Dec 2022 | 192.16B |
| Q3 FY2022 | 30 Sept 2022 | 159.12B |
| Q2 FY2022 | 30 Jun 2022 | 150.98B |
| Q1 FY2022 | 31 Mar 2022 | 159.85B |
| Q4 FY2021 | 31 Dec 2021 | 169.15B |
| Q3 FY2021 | 30 Sept 2021 | 183.56B |
| Q2 FY2021 | 30 Jun 2021 | 167.43B |
| Q1 FY2021 | 31 Mar 2021 | 136.13B |
| Q4 FY2020 | 31 Dec 2020 | 163.65B |
| Q3 FY2020 | 30 Sept 2020 | 151.60B |
| Q2 FY2020 | 30 Jun 2020 | 146.39B |
| Q1 FY2020 | 31 Mar 2020 | 93.38B |
| Q4 FY2019 | 31 Dec 2019 | 96.66B |
| Q3 FY2019 | 30 Sept 2019 | 88.94B |
| Q2 FY2019 | 30 Jun 2019 | 74.55B |
| Q1 FY2019 | 31 Mar 2019 | 72.39B |
| Q4 FY2018 | 31 Dec 2018 | 65.98B |
| Q3 FY2018 | 30 Sept 2018 | 64.20B |
| Q2 FY2018 | 30 Jun 2018 | 59.74B |
| Q1 FY2018 | 31 Mar 2018 | 80.12B |
| Q4 FY2017 | 31 Dec 2017 | 62.85B |
| Q3 FY2017 | 30 Sept 2017 | 87.90B |
| Q2 FY2017 | 30 Jun 2017 | 84.65B |
| Q1 FY2017 | 31 Mar 2017 | 80.60B |
| Q4 FY2016 | 31 Dec 2016 | 70.42B |
| Q3 FY2016 | 30 Sept 2016 | 67.98B |
| Q2 FY2016 | 30 Jun 2016 | 72.95B |
| Q1 FY2016 | 31 Mar 2016 | 55.25B |
| Q4 FY2015 | 31 Dec 2015 | 52.78B |
| Q3 FY2015 | 30 Sept 2015 | 35.80B |
| Q2 FY2015 | 30 Jun 2015 | 34.20B |
| Q1 FY2015 | 31 Mar 2015 | 30.06B |
| Q4 FY2014 | 31 Dec 2014 | 20.84B |
| Q3 FY2014 | 30 Sept 2014 | 14.27B |
| Q2 FY2014 | 30 Jun 2014 | 13.06B |
| Q1 FY2014 | 31 Mar 2014 | 12.44B |
| Q4 FY2013 | 31 Dec 2013 | 10.79B |
| Q3 FY2013 | 30 Sept 2013 | 12.23B |
| Q2 FY2013 | 30 Jun 2013 | 8.25B |
| Q1 FY2013 | 31 Mar 2013 | 6.86B |
| Q4 FY2012 | 31 Dec 2012 | 3.78B |
| Q3 FY2012 | 30 Sept 2012 | 2.85B |
| Q2 FY2012 | 30 Jun 2012 | 1.72B |
| Q1 FY2012 | 31 Mar 2012 | 1.58B |
| Q4 FY2011 | 31 Dec 2011 | 1.68B |
| Q3 FY2011 | 30 Sept 2011 | 1.63B |
| Q2 FY2011 | 30 Jun 2011 | 3.13B |
| Q1 FY2011 | 31 Mar 2011 | 3.19B |
| Q4 FY2010 | 31 Dec 2010 | 3.38B |
| Q3 FY2010 | 30 Sept 2010 | 2.83B |
| Q2 FY2010 | 30 Jun 2010 | 2.73B |
| Q1 FY2010 | 31 Mar 2010 | 3.39B |
| Q4 FY2009 | 31 Dec 2009 | 3.52B |
| Q3 FY2009 | 30 Sept 2009 | 6.02B |
| Q2 FY2009 | 30 Jun 2009 | 8.36B |
| Q1 FY2009 | 31 Mar 2009 | 9.52B |
See also:P/E ratio,P/S ratio,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about Genmab A's market cap
Source: Financial Modeling Prep
